FORMULATION AND DEVELOPMENT OF LORNOXICAM BILAYER TABLETS
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 6
Abstract
Point of present examination work was attempted to figure bilayer tablets of lornoxicam through its joining of oral measurements frame that can release lornoxicam promptly in addition maintained sustained release of lornoxicam for 24 hrs to improve oral bioavailability of lornoxicam. Primary target of this work was plan of bilayer tablets utilizing superdisintegrant Kyron 314 for smart discharge layer Polyox 303 for supporting discharge layer made out of two unique classes of medications by utilizing straight forward simple to-scale-up definition system. The in vitro dissolution study of the prepared bilayer tablets showed a controlled release of active drugs over a period of 24 hours
Authors and Affiliations
D R Nagesh
Keywords
Related Articles
- EP ID EP296838
- DOI 10.22270/jddt.v7i6.1534
- Views 83
- Downloads 0
FORMULATION, CHARACTERIZATION AND PHARMACOKINETIC EVALUATION OF NARINGENIN- LOADED GASTRORETENTIVE MUCOADHESIVE POLYMERIC NANOSYSTEM FOR ORAL DRUG DELIVERY
Nanoparticles mediated oral drug delivery system has attracted great attention in pharmacology to attain improved therapeutic index of chemotherapeutic drugs. In the present study, naringenin (NRG) - loaded gastroretenti...
HEPATOPROTECTIVE ACTIVITY OF THE EXTRACT OF CRATAEVA NURVALA BARK AGAINST CCL4 INDUCED HEPATOTOXICITY IN RATS
The present work is focused on investigation of hepatoprotective activity of bark of Crataeva nurvala. It’s hepatoprotective activity was studied in the form of its aqueous and ethanolic extract and its isolated compound...
Mini Review: Nano-Technology based Drug Deliveries
Targeted drug delivery with nano-technology has been researched and identified as being efficient across many treatment conditions. This review assesses some of the existing research work and evidence practice in using n...
PHYSICOCHEMICAL CHARACTERIZATION OF ACID MODIFIED DIOSCOREA STARCH AND ITS EVALUATION AS DIRECTLY COMPRESSIBLE EXCIPIENT IN TABLET FORMULATION
D. abyssinica was partially hydrolyzed in 6% HCl solution at room temperature for different lengths of time, (2, 4, 8, 16, and 32 days), dried using oven- and spray- drying techniques and subsequently investigated as dir...
FORMULATION, DEVELOPMENT AND CHARACTERIZATION OF SOLID LIPID NANOPARTICLES OF GEMCITABINE HYDROCHLORIDE
Gemcitabine Hydrochloride is a BCS class III drug of choice in the treatment of cancer, as a single or in combination chemotherapy. However, its bioavailability is a major concern due to its short half-life. Solid lipid...